Q BioMed Inc.
QBIO
$0.00
$0.000.00%
OTC PK
02/28/2023 | 11/30/2022 | 08/31/2022 | 05/31/2022 | 02/28/2022 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 23.20K | 50.00K | 137.80K | 27.20K | 137.20K |
Total Receivables | -- | 11.50K | 11.50K | 74.30K | 27.70K |
Inventory | -- | -- | 22.70K | 22.40K | -- |
Prepaid Expenses | 10.80K | 10.80K | 13.50K | 21.20K | 36.00K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 34.00K | 72.30K | 185.50K | 145.10K | 200.90K |
|
|||||
Total Current Assets | 34.00K | 72.30K | 185.50K | 145.10K | 200.90K |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 287.50K | 300.00K | 312.50K | 325.00K | 337.50K |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 3.46M | 3.52M | 498.00K | 470.10K | 538.40K |
|
|||||
Total Accounts Payable | 2.25M | 2.13M | 2.08M | 1.95M | 1.80M |
Total Accrued Expenses | 3.48M | 1.80M | 1.64M | 1.42M | 1.22M |
Short-term Debt | 4.08M | 4.11M | 3.77M | 3.42M | 3.35M |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | 91.40K | 91.20K | 240.00K | 774.10K | -- |
Total Other Current Liabilities | 91.40K | 91.20K | 240.00K | 774.10K | -- |
Total Current Liabilities | 9.91M | 8.13M | 7.73M | 7.56M | 6.37M |
|
|||||
Total Current Liabilities | 9.91M | 8.13M | 7.73M | 7.56M | 6.37M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | 4.08M | 4.11M | 3.77M | 3.42M | 3.35M |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | 0.00 | -- | -- | -- |
Total Liabilities | 9.91M | 8.13M | 7.73M | 7.56M | 6.37M |
|
|||||
Common Stock & APIC | 56.69M | 56.39M | 55.91M | 54.99M | 54.43M |
Retained Earnings | -68.32M | -66.10M | -68.40M | -67.60M | -66.33M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -11.63M | -9.70M | -12.49M | -12.62M | -11.90M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | 5.19M | 5.09M | 5.26M | 5.53M | 6.07M |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | 5.19M | 5.09M | 5.26M | 5.53M | 6.07M |
|
|||||
Total Common Equity | -11.63M | -9.70M | -12.49M | -12.62M | -11.90M |
Total Preferred Equity | 5.19M | 5.09M | 5.26M | 5.53M | 6.07M |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -6.44M | -4.62M | -7.23M | -7.09M | -5.83M |
|